1. Home
  2. FBIOP vs VSME Comparison

FBIOP vs VSME Comparison

Compare FBIOP & VSME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIOP
  • VSME
  • Stock Information
  • Founded
  • FBIOP N/A
  • VSME 2013
  • Country
  • FBIOP United States
  • VSME Hong Kong
  • Employees
  • FBIOP 101
  • VSME N/A
  • Industry
  • FBIOP Biotechnology: Pharmaceutical Preparations
  • VSME
  • Sector
  • FBIOP Health Care
  • VSME
  • Exchange
  • FBIOP Nasdaq
  • VSME Nasdaq
  • Market Cap
  • FBIOP N/A
  • VSME N/A
  • IPO Year
  • FBIOP N/A
  • VSME 2023
  • Fundamental
  • Price
  • FBIOP $6.93
  • VSME $1.34
  • Analyst Decision
  • FBIOP
  • VSME
  • Analyst Count
  • FBIOP 0
  • VSME 0
  • Target Price
  • FBIOP N/A
  • VSME N/A
  • AVG Volume (30 Days)
  • FBIOP N/A
  • VSME 296.3K
  • Earning Date
  • FBIOP N/A
  • VSME 08-12-2025
  • Dividend Yield
  • FBIOP N/A
  • VSME N/A
  • EPS Growth
  • FBIOP N/A
  • VSME N/A
  • EPS
  • FBIOP N/A
  • VSME N/A
  • Revenue
  • FBIOP N/A
  • VSME $8,248,108.00
  • Revenue This Year
  • FBIOP N/A
  • VSME N/A
  • Revenue Next Year
  • FBIOP N/A
  • VSME N/A
  • P/E Ratio
  • FBIOP N/A
  • VSME N/A
  • Revenue Growth
  • FBIOP N/A
  • VSME 3.22
  • 52 Week Low
  • FBIOP N/A
  • VSME $0.51
  • 52 Week High
  • FBIOP N/A
  • VSME $3.69
  • Technical
  • Relative Strength Index (RSI)
  • FBIOP 36.60
  • VSME 64.52
  • Support Level
  • FBIOP $6.56
  • VSME $1.25
  • Resistance Level
  • FBIOP $7.23
  • VSME $1.71
  • Average True Range (ATR)
  • FBIOP 0.52
  • VSME 0.15
  • MACD
  • FBIOP -0.09
  • VSME 0.02
  • Stochastic Oscillator
  • FBIOP 21.08
  • VSME 43.94

About FBIOP Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.

Share on Social Networks: